Literature DB >> 24890549

Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.

Jessie Teng1, Sally Abell, Rodney J Hicks, Michael S Hofman, Nirupa Sachithanandan, Penny McKelvie, Richard J MacIsaac.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24890549     DOI: 10.1111/cen.12519

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Effect of Locally Administered Denosumab on Bone Graft Healing in Rabbit Critical-Size Calvarial Defects.

Authors:  Taha Özer; Özgür Başlarlı; Alper Aktaş; Emre Barış; Mert Ocak
Journal:  Indian J Orthop       Date:  2022-06-27       Impact factor: 1.033

Review 2.  Denosumab: a new agent in the management of hypercalcemia of malignancy.

Authors:  Sonali Thosani; Mimi I Hu
Journal:  Future Oncol       Date:  2015-09-25       Impact factor: 3.404

3.  Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy.

Authors:  Sakura Iizumi; Tatsunori Shimoi; Tadaaki Nishikawa; Atsuko Kitano; Shinsuke Sasada; Akihiko Shimomura; Emi Noguchi; Mayu Yunokawa; Kan Yonemori; Chikako Shimizu; Yasuhiro Fujiwara; Kenji Tamura
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

4.  Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.

Authors:  Norihiro Ashihara; Koji Nakajima; Yoshiyuki Nakamura; Mutsuhiro Kobayashi; Kumiko Shirahata; Chika Maeda; Takeshi Uehara; Daisuke Gomi; Nobuo Ito
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

5.  A DRAMATIC RESPONSE TO DENOSUMAB: PROTRACTED HYPOCALCEMIA RELATED TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1-ASSOCIATED ADULT T-CELL LEUKEMIA/LYMPHOMA.

Authors:  Emily Anne Japp; Michal Kasher Meron; Joel Zonszein
Journal:  AACE Clin Case Rep       Date:  2019-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.